May 12 (Reuters) - Sol Gel Technologies Ltd SLGL.O :
* SOL-GEL TECHNOLOGIES REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* SOL GEL TECHNOLOGIES LTD - SOL-GEL HAS CASH RUNWAY INTO
SECOND
HALF OF 2025
* SOL GEL TECHNOLOGIES LTD - ON TRACK TO ADVANCE ORPHAN DRUG
CANDIDATE, SGT-610 FOR GORLIN SYNDROME INTO PHASE 3 TESTING IN
LATE 2023
* SOL GEL TECHNOLOGIES LTD - QTRLY LOSS OF $0.41 PER BASIC
AND
DILUTED SHARE
Source text for Eikon: ID:nGNX5RRCmk
Further company coverage: SLGL.O
((Reuters.Briefs@thomsonreuters.com;))